Replicor HEPDART演示文稿

StephenW

10.12.2019         HEPDART 2019         Kauai, USA         Beneficial effects of transaminase flares and predicting virologic control and functional cure during NAP therapy           Replicor REP 401 301 Flares versus outcome poster O3 HEPDART 2019 FINAL
http://replicor.com/wp-content/u ... DART-2019-FINAL.pdf

10.12.2019         HEPDART 2019         Kauai, USA         Final follow-up data from REP 401 (HBV) and REP 301-LTF (HBV / HDV)         Replicor REP 401 301-LTF Complete follow-up poster P15 HEPDART 2019 FINAL
http://replicor.com/wp-content/u ... DART-2019-FINAL.pdf

09.12.2019         HEPDART 2019         Kauai, USA         Detailed data presentation of transfection artifacts with NAPs in vitro         Assessing the in vitro activity of NAPs in HBV
http://replicor.com/wp-content/u ... f-NAPs-in-HBV-1.pdf

09.12.2019         HEPDART 2019         Kauai, USA         Accurately assessing in vitro activity of NAPs Poster         Accurately assessing in vitro activity of NAPs Poster
http://replicor.com/wp-content/uploads/2019/12/Accurately-assessing-in-vitro-activity-of-NAPs-Poster.pdf

10.12.2019 HEPDART 2019美国考艾岛转氨酶耀斑的有益效果并预测NAP治疗期间的病毒学控制和功能治愈复制品REP 401301耀斑与结果海报O3 HEPDART 2019 FINAL

2019年12月10日HEPDART 2019美国考艾岛REP 401（HBV）和REP 301-LTF（HBV / HDV）复制品的最终随访数据REP 401 301-LTF完成后续海报P15 HEPDART 2019 FINAL

2019年9月9日HEPDART 2019美国考艾岛带有NAP的体外转染工件的详细数据展示评估HBV中NAP的体外活性

2019年9月12日HEPDART 2019美国考艾岛准确评估NAP的体外活性海报准确评估NAP的体外活性海报

齐欢畅

咬牙硬挺

这家伙快成了笑话了，等了它近十年了。